Lv4
790 积分 2024-06-19 加入
[Expert consensus on ensartinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer]
4个月前
已完结
Higher Dose Icotinib in Treating Non-Small Cell Lung Cancer Patients Who Progressed with Conventional Dose of Icotinib
4个月前
已完结
Therapeutic strategies to overcome ALK-fusion and BRAF-mutation as acquired resistance mechanism in EGFR-mutated non-small cell lung cancer: two case reports
4个月前
已完结
Case report: MSI-H, EGFR mutation, and ground-glass nodules as diffuse pulmonary hematogenous metastases
4个月前
已完结
SUCCESSFUL TREATMENT OF SWITCHING EGFR-TKI FOR ADVANCED LUNG ADENOCARCINOMA BECAUSE OF INTERSTITIAL LUNG DISEASE
4个月前
已完结
Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis
4个月前
已完结
Risk assessment of drugs associated with DRESS syndrome based on publication frequency: A systematic review
4个月前
已完结
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review
4个月前
已完结
Acute generalized exanthematous pustulosis induced by icotinib: a case report and literature review
4个月前
已完结
Case report: Treatment with ensartinib shows good response to SQSTM1-ALK fusion in lung adenocarcinoma
5个月前
已完结
皖公网安备34019202002308
